T4 RNA Ligase 1

T4 RNA Ligase 1 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • 종

    Escherichia phage T4 (1)

  • 태그

    His Tag (1)

  • 마커

    Unconjugated (1)

제품 번호종발현 시스템제품 설명단백질 구조순도특성
Escherichia phage T4
E. coli
T4 RNA Ligase 1(10U/ul)
총 수량1
  • 1

T4 RNA Ligase 1분자 배경

Circular RNAs (circRNA) is a class of natural (biogenic) or synthetic closed RNA without 5' or 3' ends. Meanwhile, their unique covalently-closed structures of circRNA prevent RNA degradation by exonucleases, thereby empowering them with high pharmaceutical stability and biostability relative to current standard-of-care linear mRNA. Natural circRNA can be non-coding RNAs as well as protein-coding RNA, the latter of which was recently discovered. The physiological functions of biogenic circRNAs, which largely remain elusive, include protein and gene sponges, cell activity modulators, and protein translation. The discovery that the circRNA levels can be correlated with some human diseases empowers circRNA with the potential as a novel type of disease biomarkers and a noncanonical class of therapeutic targets. Recently, synthetic circRNA have been engineered to explore their applications as a novel class of mRNA therapeutics and vaccines.(Liu, Xiang et al. “Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines.” Journal of controlled release : official journal of the Controlled Release Society vol. 348 (2022): 84-94. doi:10.1016/j.jconrel.2022.05.043)

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
ItolizumabT-1-hT; EQ-001; T-1-h; h-T1; Bmab-600ApprovedBiocon Ltd, Center Of Molecular Immunology, Biotech Pharmaceuticals Co LtdAlzumabIndiaPlaque psoriasisBiocon Ltd2013-01-01Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis
상세
  • 제품 목록
  • 시판 약물 정보